Literature DB >> 10756118

Inhomogeneous transmural conduction during early ischaemia in patients with coronary artery disease.

P Taggart1, P M Sutton, T Opthof, R Coronel, R Trimlett, W Pugsley, P Kallis.   

Abstract

Electrical inhomogeneity and conduction slowing are critical factors in the initiation and maintenance of ventricular arrhythmias during early ischaemia. Studies in animal models have shown delay in epicardial activation compared to endocardial activation. Epicardial activation delay has been attributed to either enhanced sensitivity of epicardium to ischaemia or to mid-myocardial conduction delay. No information is available in humans and in particular in patients with chronic ischaemia due to coronary artery disease who may have altered electrophysiological properties. Twenty-three patients undergoing routine coronary surgery were studied. All had severe two or three vessel coronary artery disease and a documented history of angina for a mean of 2.4 years. On cardiopulmonary bypass a 3 min period of ischaemia was created by cross clamping the aorta between the input from the pump oxygenator and the coronary arteries. During atrial pacing (normal endocardial to epicardial activation) intramyocardial activation time within the left ventricular free wall between subendocardial and subepicardial plunge electrode terminals, increased from 12.7+/-1.5 ms (control) to 28.2+/-3.2 ms after 3 min ischaemia at the base. At the apex, the activation time increase (over the same distance) was less (19.5+/-2 ms at 3 min ischaemia). This difference in increase in activation time at the base and apex was significant (P<0.05). At the apex the ischaemia induced activation delay occurred primarily over the endocardial half of the wall, whereas the opposite was observed at the base of the heart. Using an epicardial electrode array stimulation along the long axis of the epicardial fibres showed minimal conduction delay during ischaemia whereas stimulation transverse to the epicardial fibres resulted in substantial conduction time prolongation, as was the case with intramural conduction. Intramural conduction during ischaemia was similar in non-infarcted regions of infarcted hearts compared to hearts with no previous MI. To conclude, in patients with coronary artery disease epicardial activation delay early during ischaemia is caused primarily by intramural delay and not by delay along the epicardium. Moreover, the ischaemia-induced transmural activation delay is inhomogeneous. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10756118     DOI: 10.1006/jmcc.2000.1105

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  58 in total

1.  Genetic engineering of somatic cells to study and improve cardiac function.

Authors:  Robert D Kirkton; Nenad Bursac
Journal:  Europace       Date:  2012-11       Impact factor: 5.214

2.  Letter by Ng and Efimov Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".

Authors:  Fu Siong Ng; Igor R Efimov
Journal:  Circulation       Date:  2016-11-01       Impact factor: 29.690

3.  Modeling and simulation of cardiac electric activity in a human cardiac tissue with multiple ischemic zones.

Authors:  Meena Pargaei; B V Rathish Kumar; Luca F Pavarino
Journal:  J Math Biol       Date:  2019-07-27       Impact factor: 2.259

Review 4.  Ischaemia-induced cellular electrical uncoupling and ventricular fibrillation.

Authors:  J R de Groot
Journal:  Neth Heart J       Date:  2002-09       Impact factor: 2.380

5.  Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.

Authors:  Tobias Bruegmann; Patrick M Boyle; Christoph C Vogt; Thomas V Karathanos; Hermenegild J Arevalo; Bernd K Fleischmann; Natalia A Trayanova; Philipp Sasse
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

6.  A computational study of mother rotor VF in the human ventricles.

Authors:  R H Keldermann; K H W J ten Tusscher; M P Nash; C P Bradley; R Hren; P Taggart; A V Panfilov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

7.  Adverse remodeling of the electrophysiological response to ischemia-reperfusion in human heart failure is associated with remodeling of metabolic gene expression.

Authors:  Fu Siong Ng; Katherine M Holzem; Aaron C Koppel; Deborah Janks; Fabiana Gordon; Andrew L Wit; Nicholas S Peters; Igor R Efimov
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-11

8.  Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner.

Authors:  Eva Querdel; Marina Reinsch; Liesa Castro; Thomas Eschenhagen; Florian Weinberger; Deniz Köse; Andrea Bähr; Svenja Reich; Birgit Geertz; Bärbel Ulmer; Mirja Schulze; Marc D Lemoine; Tobias Krause; Marta Lemme; Jascha Sani; Aya Shibamiya; Tim Stüdemann; Maria Köhne; Constantin von Bibra; Nadja Hornaschewitz; Simon Pecha; Yusuf Nejahsie; Ingra Mannhardt; Torsten Christ; Hermann Reichenspurner; Arne Hansen; Nikolai Klymiuk; M Krane; C Kupatt
Journal:  Circulation       Date:  2021-03-02       Impact factor: 29.690

9.  Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block.

Authors:  Jakub Tomek; Alfonso Bueno-Orovio; Elisa Passini; Xin Zhou; Ana Minchole; Oliver Britton; Chiara Bartolucci; Stefano Severi; Alvin Shrier; Laszlo Virag; Andras Varro; Blanca Rodriguez
Journal:  Elife       Date:  2019-12-24       Impact factor: 8.140

Review 10.  Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Peng Wu; Gang Deng; Xiyalatu Sai; Huiming Guo; Huanlei Huang; Ping Zhu
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.